Last data update: Sep 23, 2024. (Total: 47723 publications since 2009)
Records 1-1 (of 1 Records) |
Query Trace: Avrich Ciesla A [original query] |
---|
Effectiveness of the original monovalent and bivalent COVID-19 vaccines against COVID-19-associated emergency department and urgent care encounters in pregnant persons who were not immunocompromised: VISION Network, June 2022-August 2023
Avrich Ciesla A , Lazariu V , Dascomb K , Irving SA , Dixon BE , Gaglani M , Naleway AL , Grannis SJ , Ball S , Kharbanda AB , Vazquez-Benitez G , Klein NP , Natarajan K , Ong TC , Embi PJ , Fleming-Dutra KE , Link-Gelles R , Zerbo O . Open Forum Infect Dis 2024 11 (9) ofae481 Pregnant people face increased risk of severe COVID-19. Current guidelines recommend updated COVID-19 vaccination (2023-2024) for those aged ≥6 months, irrespective of pregnancy status. To refine recommendations for pregnant people, further data are needed. Using a test-negative design, we evaluated COVID-19 vaccine effectiveness against medically attended COVID-19 with COVID-19-like illness among pregnant people aged 18 to 45 years during June 2022 to August 2023. When doses were received during pregnancy, vaccine effectiveness was 52% (95% CI, 29%-67%); when received <6 months prior to pregnancy, 28% (95% CI, 11%-42%); and when received ≥6 months prior to pregnancy, 6% (95% CI, -11% to 21%). Pregnant people should stay up-to-date with recommended COVID-19 vaccination. |
- Page last reviewed:Feb 1, 2024
- Page last updated:Sep 23, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure